Mark C. Lavigne
Impact in
-
- Menopause: Health Impacts and Treatments
- Hormonal Regulation and Hypertension
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 5
-
- Asthma and respiratory diseases 3
- Co-authors
- Peter W. Ramwell (6 shared papers)Michel Y. Farhat (2 shared papers)Thomas L. Leto (7 shared papers)Michael J. Eppihimer (6 shared papers)Harry L. Malech (3 shared papers)Steven M. Holland (2 shared papers)Philip M. Murphy (3 shared papers)Ji‐Liang Gao (3 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)The FASEB Journal (2 papers)Journal of Biological Chemistry (2 papers)Journal of Cardiovascular Pharmacology (2 papers)Cellular Immunology (1 paper)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Mark C. Lavigne
22 papers receiving 1.2k citations
Mark C. Lavigne's Hit Papers
Peers
Comparison fields: 5 of 92
- Endocrinology, Diabetes and Metabolism 257
- Neurology 102
- Physiology 293
- Immunology 236
- Genetics 266
Countries citing papers authored by Mark C. Lavigne
This map shows the geographic impact of Mark C. Lavigne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Lavigne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Lavigne more than expected).
Fields of papers citing papers by Mark C. Lavigne
This network shows the impact of papers produced by Mark C. Lavigne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Lavigne. The network helps show where Mark C. Lavigne may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark C. Lavigne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The vascular protective effects of estrogen Hit paper breakdown → | 1996 | 533 |
| 2 | 2001 | 143 | |
| 3 | 2001 | 108 | |
| 4 | 1998 | 63 | |
| 5 | 2005 | 58 | |
| 6 | 2004 | 53 | |
| 7 | 1988 | 52 | |
| 8 | 2000 | 50 | |
| 9 | 2001 | 30 | |
| 10 | 2011 | 21 | |
| 11 | 2002 | 21 | |
| 12 | 1996 | 17 | |
| 13 | 1998 | 16 | |
| 14 | 2020 | 15 | |
| 15 | 1999 | 9 | |
| 16 | 2007 | 8 | |
| 17 | 1999 | 6 | |
| 18 | 2016 | 6 | |
| 19 | 2010 | 5 | |
| 20 | 2004 | 3 |
About Mark C. Lavigne
Mark C. Lavigne is a scholar working on Immunology, Physiology, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Estrogen and related hormone effects (4 papers), S100 Proteins and Annexins (3 papers), Inflammatory mediators and NSAID effects (3 papers), Coronary Interventions and Diagnostics (3 papers), Menopause: Health Impacts and Treatments (3 papers), Cell Adhesion Molecules Research (3 papers) and Asthma and respiratory diseases (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (257 citations), Neurology (102 citations), Physiology (293 citations), Immunology (236 citations) and Genetics (266 citations). Mark C. Lavigne has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Peter W. Ramwell, Michel Y. Farhat, Thomas L. Leto, Michael J. Eppihimer, Harry L. Malech, Steven M. Holland, Philip M. Murphy, Ji‐Liang Gao, You‐Hong Cui and H. Lee Tiffany. Their work appears in journals such as Biochemical and Biophysical Research Communications, The FASEB Journal, Journal of Biological Chemistry, Journal of Cardiovascular Pharmacology and Cellular Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.